Methylphenidate for Attention Problems After Pediatric TBI

Completed · Phase 4 · Has a placebo group

Conditions studied: Traumatic Brain Injury, TBI, ADHD

In brief

Traumatic Brain Injury (TBI) - methylphenidate treatment

Key facts

Study ID

NCT01933217

Run by

Children's Hospital Medical Center, Cincinnati

People needed

26

Starts

2013-11-01

Expected to finish

2016-08-01

Last updated by the study team

2020-06-04

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Between ages of 6-17
• Sustained Moderate to Severe TBI
• TBI occurred at least 6 months prior to beginning the study
• TBI occurred no earlier than 5 years of age
• Positive endorsement of 6 out of 9 items on the Vanderbilt ADHD inattention or hyperactivity scale

You may not qualify if…

• History of developmental disability or mental retardation
• Current active participation in ADHD-related behavioral intervention
• History of psychiatric condition requiring an inpatient admission in past 12 months
• Actively taking medications with a contraindication to Concerta that cannot be discontinued
• Current use of stimulant medication or ADHD specific medications that cannot be discontinued
• Non-blunt head injury
• Family history of arrhythmia
• Pregnancy

Where it is running

• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.